- cafead Jan 31, 2024 at 10:42: PM
via Gilead Sciences and Arcus Biosciences said they’ve expanded their three-year-old collaboration.
An equity stake in Arcus, board seat for Gilead’s commercial chief and a streamlined immuno-oncology strategy are among the considerations.
article source
An equity stake in Arcus, board seat for Gilead’s commercial chief and a streamlined immuno-oncology strategy are among the considerations.
article source